Private equity's grip on insurance M&A hits a 10-year low

Fidelis's $163.3 million buyout of CVC's entire stake at $19 a share — a 23% discount to book value — reads at first as a straightforward capital cleanup. It is the clearest sign yet that private equity's decade-long run as the dominant buyer of insurance assets is over, and that the capital replacing it is coming from strategic and public balance sheets.

Insurance AUM Journal's midyear outlook frames the shift: private equity's share of insurance M&A has fallen to a 10-year low, and while the overall deal market is recovering, the recovery is lopsided because strategic buyers are doing the deals. The sponsors that spent the 2010s assembling insurance platforms through leveraged rollups are, in the case of Fidelis, accepting that discount to get out.

The Fidelis transaction is an exit that retires CVC's entire position and clears the way for the planned Pelagos rebrand. The price tells you the state of the market: a sale at 23% below book value means the private buyer is not willing to pay accounting value for a sponsor's stake. In the rollup era, sponsors could sell insurance assets at a premium to book because the buyer was another sponsor with leverage; that buyer is gone, leaving strategics with integration plans and public companies with mandated capital, neither paying sponsor multiples.

The same cleanup is visible in the third-party capital market, where RenRe has handed capital back and third-party assets have fallen $540 million from a $9.08 billion record, per PWD's tracking. The capital is being returned because rates no longer clear, a matching of capacity to a softer market rather than a loss of confidence.